QualityStocks News Alert
  The QualityStocks Daily Newsletter for Thursday January 15th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


OTC Reporter (HTDS)


Stock Egg.com (BKUNA)


Stock Stars (SDVI)

The QualityStocks Daily

Visualant Inc. (VSUL)
UFP Technologies Inc. (UFPT)
Accuride Corporation (AURD)
Enterprise Oilfield Group Inc. (E.TO)

Javelin Pharmaceuticals Inc. (JAV)
InterMune Inc. (ITMN)
Cypress Bioscience Inc. (CYPB)
Northern Explorations Ltd. (NXPN)


Visualant Inc. (VSUL)

SmallCap Voice reported last week on Visualant Inc. (VSUL) and today we choose to highlight the Company as "One to Watch" here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Visualant Inc.'s focus is to capitalize on the business opportunities in national security, document forgery/fraud, brand protection, label fraud, and product tampering. They develop low-cost, high speed, light-based security and quality control solutions. Visualant Inc. has their corporate headquarters in Seattle , Washington . Founded in 1998, they are part of the Business Services industry.

The Company's patent-pending technology uses controlled illumination with specific bands of light. It measures and records what is viewable, and manages data gathered in an innovative manner. This enables devices to establish a unique spectral signature for both individual and classes of items. When matched against existing databases, the spectral signatures allow precise identification and authentication of any item or substance.

Visualant's color technology provides multi-dimensional spectral-based pattern file creation and matching. One can create color pattern files from any digital photograph or scan. There is no need to reprint, recreate, recall, or modify existing digital source documents. Pattern files matched against existing databases detect identity crime, forgery, counterfeiting, and other frauds. The technology uses full spectrum color patterns. They are more accurate than black and white systems.

In December, Visualant Inc. announced the execution of a strategic development agreement with RatLab LLC of Seattle. The agreement involves a non-commercial license from Visualant and a reciprocal license to certain RatLab LLC technology. This agreement will enable continuing development of the core Visualant proprietary spectral pattern based color technology.

Last Tuesday, Visualant announced the execution of their first commercial licensing agreement with RatLab LLC.

The license provides Visualant with an equity participation in a "to be formed" RatLab LLC affiliate and a market rate royalty. The fields of use include medical diagnostics, agricultural, environmental applications, and gemology.

We are tracking Visualant Inc. (VSUL) on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Today, Visualant Inc. (VSUL) closed at $0.10 up $0.04 or 66.67 percent. Volume was 64,200 shares. The 3-month average volume is 10,179.70.

UFP Technologies Inc. (UFPT)

MicroCap Gems and Taglich reported earlier on UFP Technologies Inc. (UFPT) and we highlight the Company here at the QualityStocks Daily Newsletter.

UFP Technologies Inc. is a leading designer and manufacturer of interior protective packaging solutions using molded fiber, vacuum-formed plastics, and molded and fabricated foam plastics. They also design and manufacture engineered component solutions using laminating, molding, and fabricating technologies. Headquartered in Georgetown , Massachusetts , the Company began in 1963. Trading on the NASDAQ Capital Market, they have eleven North American manufacturing locations.

UFP Technologies Inc. mainly serves the automotive, computers and electronics, medical, aerospace and defense, consumer, and industrial markets. Their core business is foam fabrication. They specialize in creating custom solutions utilizing diverse materials and their converting expertise.

The Company has three major brands that they market. These are United Foam, Simco Automotive, and Molded Fiber. United Foam creates high-performance packaging, part, and product solutions from foams, plastics, and specialty fabrics. They engineer unique, cost-effective solutions for a wide variety of critical applications.

The Company's Simco Automotive provides high-quality development, engineering, and manufacturing services for interior trim and interior structural components made from a broad spectrum of advanced materials. UFP Technologies' Molded Fiber brand is the leading designer and manufacturer of interior packaging solutions made from 100 percent recycled paper. Their solutions reduce labor and save space while providing protection at every stage of a product's sales cycle. They are also cost-effective and environmentally friendly.

In November, UFP Technologies reported net income of $1.2 million or $0.20 per diluted common share outstanding for their third quarter ended September 30, 2008. This compares to net income of $883,000 or $0.15 per diluted common share outstanding for the third quarter of 2007. Sales for the quarter were $27.5 million or 19.9 percent higher than 2007 third quarter sales of $22.9 million.

For the nine-month period ended September 30, 2008, they reported net income of $4.0 million or $0.63 per diluted common share outstanding, compared to net income of $2.4 million or $0.41 per diluted common share outstanding in the same period in 2007. Sales for the nine-month period ended September 30, 2008, were $84.0 million or 23.2 percent higher than last years sales of $68.1 million in the same period.

UFP Technologies Inc. (UFPT) closed today's session at $5.45 up $0.26 or 5.01 percent. Volume was 10,459 for a 3-month average volume of 26,726.60.

Accuride Corporation (AURD)

Standout Stocks reported today on Accuride Corporation (AURD) and we are too here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Accuride Corporation engages in the design, manufacture, and distribution of components for trucks, trailers, and other vehicles. Founded in 1986, the Company has their corporate headquarters in Evansville , Indiana , and they market their products under six brand names. They have a current market capitalization of $15.00 million as part of the Trucks and Other Vehicles Industry in the Consumer Goods sector.

Accuride Corporation is one of the largest and most diversified manufacturers and suppliers of commercial vehicle components in North America . Their product brand names are Accuride, Gunite, Imperial, Bostrom, Fabco, and Brillion. The Company's products include commercial vehicle wheels, wheel-end components and assemblies, truck body and chassis parts, seating assemblies, and other commercial vehicle components.

Their Accuride Wheels business unit makes steel and aluminum wheels. The Gunite unit manufactures wheel-end components. Their Brillion unit manufactures iron castings and non-powered farm equipment. The Imperial unit makes truck body and chassis components. Bostrom makes seating assemblies and Fabco makes steerable drive axles, gearboxes, and other truck components.

On December 17, Accuride Corporation introduced their Highway Original brand. They are gearing this brand to the commercial vehicle aftermarket. They also introduced their first Highway Original branded line of customized bumpers. They are marketing bumpers to fit most popular heavy-duty truck makes and models. They have different end style options, including Texas Square , Tapered, Open End, and others. They offer these in chrome steel, black prime-painted steel, and stainless steel. Customers can also design a bumper through the brand's website at www.highwayoriginal.com.

Accuride Corporation serves original equipment manufacturers. These companies manufacture heavy and medium duty trucks, commercial trailers, light trucks, buses, and specialty and military vehicles. The Company also serves aftermarket suppliers, such as OEM dealer networks, wholesale distributors, and aftermarket buying groups. Accuride operates in the United States , Canada , and Mexico .

Accuride Corporation (AURD) closed today's session at $0.40 up $0.05 or 14.29 percent. Volume was 414,180 for a 3-month average volume of 462,020.

Enterprise Oilfield Group Inc. (E.TO)

Today we are highlighting Enterprise Oilfield Group Inc. (E.TO) here at the QualityStocks Daily Newsletter.

Enterprise Oilfield Group Inc. is a pipeline construction and horizontal directional drilling company with a primary focus on Alberta , Canada 's oilfield and utility infrastructure markets. The company's pipeline construction service targets small-diameter pipeline construction projects, primarily on producing oil and gas fields. The utility infrastructure and directional drilling business provides installation of underground power, telecommunications, and natural gas lines to the utility infrastructure sector. Enterprise Oilfield Group Inc. trades on the TSX Exchange and has their headquarters in St. Albert , Alberta .

Since its inception, Enterprise Oilfield Group has maintained its focus on becoming the largest, most comprehensive pipeline construction and maintenance company in Alberta. The company is now implementing a strategy of acquiring and consolidating small to mid size pipeline construction companies to meet its near term goal of generating more than $100 million in annual sales revenue. Enterprise Oil is specifically targeting companies that have a proven track record, are well managed, and financially successful.

Their Pipeline Construction operations are in Slave Lake , Peace River, and Wainwright, Alberta . They offer services such as pipeline construction; pipeline repair and maintenance; facilities construction and maintenance and directional drilling and large diameter tunneling. They also engage in wellhead tie-ins, CO2 and water injection projects, underground utilities installation, and road and lease construction.

The company has a growing equipment asset base of approximately $18 million, including a fleet of more than 250 trucks and heavy equipment, and has been successful in attracting blue-chip clients such as Devon (NYSE: DVN), Canadian Natural (NYSE: CNQ), EnCana (NYSE: ECA), Apache (NYSE: APA), ConocoPhillips (NYSE: COP), and Penn West Energy Trust (NYSE: PWE).

President and CEO Leonard D. Jaroszuk, who has two decades of extensive experience in the real estate, construction, natural resources, and exploration industries, leads the company. He took a leading role in developing Enterprise Oilfield's early growth and has served as a director on several Oil and Gas service and manufacturing companies. Jaroszuk's demanding management style, together with his understanding and vision, has put the company on track to become an industry leader in the pipeline construction industry in Alberta.

Enterprise Oilfield Group Inc. (E.TO) closed today's session at $0.195 down $0.01 or 4.88 percent. Volume was 20,500 for a 3-month average volume of 65,137.50.

Javelin Pharmaceuticals Inc. (JAV)

Today, StockEgg.com reported on Javelin Pharmaceuticals Inc. (JAV), Knobias did recently, and today we highlight the Company as well here at the QualityStocks Daily Newsletter.

Founded in 1998, Javelin Pharmaceuticals Inc., with their subsidiaries, engages in the research, development, and commercialization of pharmaceutical products for pain relief in the United States and Europe . The Company trades on the American Stock Exchange (AMEX) and has their corporate headquarters in Cambridge , Massachusetts . They also have offices in Lake Success , New York ; Cambridge , United Kingdom ; and Cologne , Germany .

As a specialty pharmaceutical company, Javelin applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs. Their product candidates address the acute moderate-to-severe pain medication market. Indications they are developing include post-operative pain, orthopedic injury pain, procedural pain, burn pain, and trauma. Javelin Pharmaceuticals Inc. has three late stage product candidates in development. These are Dyloject™ (diclofenac sodium, injectable), Rylomine™ (intranasal morphine), and PMI-150 (intranasal ketamine).

Today, the Company announced that they have entered into an exclusive European marketing partnership for Dyloject®. This is with Therabel Pharma N.V. and is worth up to $71 million in upfront, sales, and regulatory milestone payments. The marketing partnership also provides for a double-digit royalty on future sales.

Dyloject is an injectable formulation of diclofenac. It is in Phase 3 clinical development in the United States and marketed in the United Kingdom . Diclofenac is a prescription nonsteroidal anti-inflammatory drug, widely prescribed to treat post-operative pain. In Dyloject's pivotal U.K. registration trial, its efficacy and safety showed significantly superior to those of the IV formulation of diclofenac now marketed in the U.K. Doses of IV formulations require buffering, dilution, and slow infusion. Dyloject comes ready to use for immediate IV bolus administration and works faster.

Martin Driscoll, Javelin's CEO, stated, "Partnering Dyloject in Europe bolsters our financial resources and extends our cash until 2010 before achieving future milestones and potential additional product partnerships. We are retaining significant upside in Dyloject's future EU growth with a high quality marketing partner while eliminating our European commercialization expenses."

Javelin Pharmaceuticals Inc. (JAV) closed today at $1.20 up $0.10 or 9.09 percent. Volume was 1,494,925 for a 3-month average volume of 284,234.

InterMune Inc. (ITMN)

Today, Greenbackers reported on InterMune Inc. (ITMN), Knobias and Momentum Traders did previously, and we are highlighting the Company here at the QualityStocks Daily Newsletter.

Founded in 1998, InterMune Inc. is a biopharmaceutical company headquartered in Brisbane , California . Trading on the NASDAQ, the Company focuses on researching, developing, and commercializing innovative therapies in pulmonology and hepatology. In pulmonology, they are developing therapies for the treatment of idiopathic pulmonary fibrosis. In hepatology, they are developing therapies focused on expanding treatment options for patients suffering from chronic hepatitis C.

InterMune Inc.'s pulmonology pipeline includes the fully enrolled Phase 3 "CAPACITY" program. This is evaluating pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis. This condition is a progressive disease. Manifestations of it are inflammation and scarring (fibrosis) of the lungs. The Company also has a research program focusing on small molecules for pulmonary disease.

For patients suffering from hepatitis C virus (HCV) infections, the Company's portfolio includes the HCV protease inhibitor compound ITMN-191. This compound is in Phase 1b development. InterMune also has a second-generation HCV protease-inhibitor research program. In addition, they have a research program evaluating a new target in hepatology.

InterMune also markets their Actimmune® (interferon gamma-1b). This has approval for the treatment of severe, malignant osteopetrosis and chronic granulomatous disease. Actimmune® has indication for reducing the frequency and severity of serious infections associated with chronic granulomatous disease. This product also has indication for delaying time to disease progression in patients with severe, malignant osteopetrosis.

InterMune Inc. has license and collaboration agreements with Hoffmann-LaRoche, Inc., F. Hoffmann-LaRoche, Ltd.; Genentech, Inc.; Connetics Corporation; and Boehringer Ingelheim International GmbH. They also have license and collaboration agreements with Novartis Corporation; Array BioPharma, Inc.; Eli Lilly & Company; and ALZA Corporation.

On Monday, InterMune reported positive results from early-stage studies of their hepatitis C drug candidate in combination with two other treatments. They said results from all six completed Phase 1b clinical trials shows ITMN-191 treated the virus, or reduced the viral load in patients. ITMN-191 is in midstage development.

InterMune Inc. (ITMN) closed Thursday's session at $9.19 up $0.52 or 6.00 percent. Volume was 1,142,903 for a 3-month average volume of 444,917.

Cypress Bioscience Inc. (CYPB)

Today, Greenbackers and Momentum Traders reported on Cypress Bioscience Inc. (CYPB), Knobias did previously, and we highlight the Company too here at the QualityStocks Daily Newsletter.

Headquartered in San Diego , California , Cypress Bioscience Inc. provides therapeutics and personalized medicine services. Listed on the NASDAQ Global Market, Cypress identifies unmet medical needs in the areas of pain, rheumatology, and physical medicine and rehabilitation. These include fibromyalgia and rheumatoid arthritis.

Cypress acquired Proprius Pharmaceuticals, Inc. in March 2008. With this acquisition, they have expanded their strategy to include providing personalized medicine services to rheumatologists. Personalized medicine services are tests validated analytically and clinically to provide physicians with information to help manage their patients' care.

The Company launched their first two novel personalized medicine services in October of 2008. These are Avise PGSM and Avise MCVSM. Avise PG is a test that supports dose optimization and therapeutic decision making for patients taking methotrexate (MTX). This is a first-line therapy for rheumatoid arthritis. Avise MCV is a test that aids in the diagnosis and prognosis of rheumatoid arthritis.

Cypress Bioscience also has several Proof of Concept (POC) stage opportunities in development. These include two pharmaceutical candidates acquired from Proprius. Cyprus continues to evaluate the acquisition of products, product candidates, technologies and companies, and other alternatives to grow their business.

Today, shares of Cypress Bioscience Inc. rose after they and their partner Forest Laboratories Inc. reported that the Food and Drug Administration approved the fibromyalgia treatment Savella. Fibromyalgia is a chronic condition that causes pain, depression, and fatigue. The companies expect Savella, or milnacipran, to hit the market by March of this year. French drugmaker Laboratoires Pierre Fabre developed milnacipran as an antidepressant but it has not received approval in the U.S. to treat depression. Cypress licensed the North American rights to the drug and developed it with Forest Laboratories Inc.

Savella is a dual-reuptake inhibitor. It blocks the reuptake of norepinephrine with higher potency than serotonin (in-vitro). These are two neurotransmitters believed to a play a central role in the symptoms of fibromyalgia.

Today, Cypress Bioscience Inc. (CYPB) closed trading at $9.61 up $2.40 or 33.29 percent. Volume was 11,701,600 significantly higher than the 3-month average of 542,961.

Northern Explorations Ltd. (NXPN)

Today, HotOTC.com, StockEgg.com, and Inside Move all reported on Northern Explorations Ltd. (NXPN) and we choose to highlight the Company as well here at the QualityStocks Daily Newsletter.

Northern Exploration Ltd. is an energy exploration Company that is working to develop natural gas assets in North America . Headquartered in Scottsdale , Arizona , their first Natural Gas Project is in Alberta , Canada . Founded in 2004, the Company lists on the OTCBB. They are an early stage company engaging in the exploration, acquisition, and development of resource projects.

Northern's Natural Gas Project has the potential to contain eight BCF of gas with associated plant, pipeline, and existing infrastructure. Yesterday, the Company announced further details of their natural gas pipeline and gas processing plant acquisition. They will acquire petroleum related assets in Alberta , Canada that include a 49 percent interest in a natural gas processing and compression facility and a natural gas pipeline. In addition, it will include additional infrastructure and certain lands associated to the infrastructure. Northern Explorations also has the option to obtain the remaining 51 percent interest over a two-year period.

The gas processing plant is capable of processing sour gas by a regenerative solution. It is also capable of sweet gas compression, gas metering, and water storage. Northern Explorations also acquires a network of five, six-inch natural gas pipelines. These connect to a major trunk line operated by Encana. They extend out to three ready for tie-in gas wells.

Today, Northern Explorations announced that their personnel and independent engineering consultants commenced a formal due diligence process on two California natural gas projects. The Company feels that an acquisition of the gas plays will be viable within the next 30 days. They base this on the preliminary conclusions of the due diligence team. They will work to acquire a majority working interest in these projects, which show a combined potential to contain up to 50 BCF of gas. The Company believes that the project, if commercially viable, may have an in-situ value of over $50 million in contained gas to a majority working-interest partner.

Northern Explorations Ltd. (NXPN) closed today at $1.18 up $0.06 or 5.36 percent. Volume was 448,963 for a 3-month average volume of 18,279.70.

The QualityStocks Company Corner

Kraig Biocraft Laboratory (KBLB)
Hunt Gold Corp. (HGLC)

Nexia Holdings, Inc. (NXHD)
Sector 10 Inc. (SECT)

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB). Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.20, which was up $0.13 or 185.71 percent from yesterday's close. Their volume today was 71,956 shares, which is significantly higher than their 3-month average volume of 2,050 shares.

Kraig Biocraft Laboratories, Inc. (KBLB) a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Daily Blog

Kraig Biocraft Laboratories, Inc. News:

Kraig Biocraft Laboratories, Inc. Announces a Large Increase in Laboratory Productivity Including a Doubling of Gene Transfers Performed

Kraig Biocraft Laboratories, Inc. Announces Research Team Member Completes Successful Trip to Overseas Laboratory to Boost Spider Silk Polymer Development

Kraig Biocraft Laboratories, Inc. Announces Acceleration of Polymer Research and Development With Another Significant Addition to Research Team

Hunt Gold Corp. (HGLC)

The QualityStocks Daily Newsletter would like to spotlight Hunt Gold Corp. (HGLC) Today, Hunt Gold Corporation closed trading at $0.0001, for no change.  Their volume today was 182,511,158 shares, which was significantly higher than their 3-month average volume of 1,435,980 shares.

Hunt Gold Corporation announced today that an additional 26 lode mining claims had been acquired at their "Mockingbird" Gold property in Arizona.

Hunt Gold Corporation (HGLC) is a gold mining and exploration company focused on the development and exploration of their “Mockingbird,” “Ambassador,” “Golden Eagle,” “Gladstone Lookout,” “Lady Alde,” “Lookout Silver,” “Starlight,” “American Flag,” “Venezia,” “Stormcloud,” “Cherry,” “Buffalo Limecap,” “Red Cloud” and “Federal” gold properties.

The company is currently in the process of drilling on its “Mockingbird” Gold Property. The property consists of approximately 2,500 acres and is located in Mohave County, Arizona. Previous mining efforts identified the property as having the potential to hold more than a million ounces of gold resource. Hunt Gold's drilling program was initiated to verify the gold mineralization previously identified by surface sampling, and to begin building a proven or probable gold resource.

The Ambassador Gold Project is located near Prescott, Arizona in the Black Hills Mining District, which is south of the Verde Mining District and west of the Cherry Creek Mining District. Each of these districts has seen significant past production of gold, silver and copper. Well-known area mines include the United Verde, United Verde Extension, Yaeger, Monarch and Logan Mines.

The Golden Eagle property is geographically located between and on trend with the Mesquite gold mine and the Picacho gold mine. Mesquite was mined by Newmont for over 15 years and produced a total of 4MM ounces gold, while Picacho produced 388,000 ounces of gold. Past exploration by UNC focused on sampling of the underground workings of the Ambassador Mine, which showed excellent gold grades at the mine exposures and the potential for developing an economic ore deposit of over 1,000,000 ounces of gold and gold equivalent silver and copper credits. Disclaimer

Hunt Gold Corp. Daily Blog

Hunt Gold Corp. News:

Hunt Gold Corporation -- Company Acquires Additional Mines & Stakes 26 Lode Mining Claims

Hunt Gold Corporation - Completion of January Drilling Campaign

Hunt Gold Corporation -- Encouraging Drilling Results

Nexia Holdings, Inc. (NXHD)

The QualityStocks Daily Newsletter would like to spotlight Nexia Holdings, Inc. (NXHD) Today, Nexia Holdings, Inc. closed trading at $0.0002, for no change from yesterday's close. Their volume today was 20,265,000 shares.

Nexia Holdings Inc. CEO Richard Surber shared his thoughts about current economic issues and the opportunities available to Nexia in a press release today.

Nexia Holdings, Inc. is a diversified holdings company with operations in health and beauty, fashion retail, and real estate. Currently, the company owns two salons, one retail store, one online retail store and three commercial properties.

The two salons, Landis Lifestyle Salon and Landis Salon, are both located in Utah. Landis Lifestyle Salon, located in Salt Lake City, is an Aveda™ Lifestyle Salon, while Landis Salon, located in Bountiful, is an Aveda™ Concept Salon. Nexia plans to grow the Landis brand to a national level with up to 5 locations in the Salt Lake region before executing a national expansion plan that could include franchise opportunities.

The retail store, operated by subsidiary Black Chandelier, sets itself apart from clothing giants such as The Gap, Hot Topic, and Target by offering eco-friendly fabrics, in-house sewers and silk screeners, and crazy models like Lisa D'Amato. The store was designed to be a tourist attraction that offers an innovative retail shopping experience.

Nexia Holdings, Inc. also has more than a decade of experience acquiring undervalued properties in the area of Salt Lake City. The company's existing portfolio includes the historic Wallace-Bennett Building (a 38,000 sq. ft. multi-story office building in Salt Lake City), a 7,000 sq. ft. one-story retail building on State Street in Salt Lake City, and 100,000 sq. ft. building on Sam's Boulevard in Kearns. The company also owns seven small parcels of undeveloped raw land in Utah and Kansas. Disclaimer

Nexia Holdings, Inc. Blog

Nexia Holdings, Inc. News:

Nexia Set to Acquire Seven Residential Properties in Northern Utah

Nexia Reports Salon Revenues of $2,113,943

Nexia Assembles New Real Estate Acquisition Team

Sector 10 Inc. (SECT)

The QualityStocks Daily Newsletter would like to spotlight Sector 10 Inc. (SECT) Today, Sector 10 Inc. closed trading at $0.09, which was up $0.02 or 28.57 percent from yesterday's close. Their volume today was 76,100 shares for a 3-month average volume of 31,054.70 shares.

Sector 10 Inc. is focused on becoming the world's leading provider of mobile and stationary emergency life response equipment. The company dedicates its efforts to restructuring a fragmented industry with its globally patented Mobile and Stationary Response Unit (”MRU” and “SRU”) product lines and saving lives.

While expanding its global client base, Sector 10 strives to remain rooted in its core competencies and operating principles. The company's strategy is to continue to invest in management and business development, increase efficiency, manage risk and further strengthen our culture. Sector 10 aims to reach corporate profitability and produce a favorable investment environment by establishing a balanced trend of growth and capital management.

The company is perfectly positioned to capitalize on an extremely fragmented industry and dominate its future growth. While billions of tax dollars are wasted in emergency response, little is spent on preparedness. Through Sector 10's pre-deployed solutions, immediate help and safety is available to those who need it most. These systems provide first aid supplies, life saving equipment, occupant tracking through a real-time 3D interface, and emergency communications.

Leading the way at Sector 10 is Pericles DeAvila who serves as the company's CEO, inventor and lead creative thinker. DeAvila is responsible for all strategic, financial and operational aspects of Sector 10 and its associated businesses. DeAvila studied business and construction management in California and also studied at the Institute University of the Azores. He fluently speaks Portuguese, Italian, French, Spanish, as well as English and has entrepreneurial experience nationally and internationally. Disclaimer


Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.

Sponsors of the Day

The QualityStocks Public Company Sponsor News


QualityStocks By The Numbers Report




About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703